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HIV infection is characterized by the progres-
sive depletion of CD4 T helper cells, eventually 
leading to AIDS and the onset of various op-
portunistic diseases. Highly active antiretroviral 
therapy interrupts HIV replication and leads to 
increases in CD4 T cell numbers and function, 
with associated clearance of many opportunis-
tic infections. Data indicate that ongoing viral 
replication within CD4 T cells is among the 
most important parameters driving the massive, 
systemic depletion of memory CD4 T cells 
during acute immunodeficiency virus infection 
(Li et al., 2005; Mattapallil et al., 2005) and the 
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HIV-1 infection results in the progressive loss of CD4 T cells. In this study, we address how 
different pathogen-specific CD4 T cells are affected by HIV infection and the cellular 
parameters involved. We found striking differences in the depletion rates between CD4  
T cells to two common opportunistic pathogens, cytomegalovirus (CMV) and Mycobacterium 
tuberculosis (MTB). CMV-specific CD4 T cells persisted after HIV infection, whereas MTB-
specific CD4 T cells were depleted rapidly. CMV-specific CD4 T cells expressed a mature 
phenotype and produced very little IL-2, but large amounts of MIP-1. In contrast, MTB-
specific CD4 T cells were less mature, and most produced IL-2 but not MIP-1. Staphylo-
coccal enterotoxin B–stimulated IL-2–producing cells were more susceptible to HIV 
infection in vitro than MIP-1–producing cells. Moreover, IL-2 production was associated 
with expression of CD25, and neutralization of IL-2 completely abrogated productive HIV 
infection in vitro. HIV DNA was found to be most abundant in IL-2–producing cells, and 
least abundant in MIP-1–producing MTB-specific CD4 T cells from HIV-infected subjects 
with active tuberculosis. These data support the hypothesis that differences in function 
affect the susceptibility of pathogen-specific CD4 T cells to HIV infection and depletion  
in vivo, providing a potential mechanism to explain the rapid loss of MTB-specific CD4  
T cells after HIV infection.
This article is distributed under the terms of an Attribution–Noncommercial–Share 
Alike–No Mirror Sites license for the first six months after the publication date 
(see http://www.rupress.org/terms). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported 
license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e2870 HIV-1 infection depletes MTB-specific CD4 T cells | Geldmacher et al.
latent infections that are tightly controlled by the adaptive 
immune system in healthy individuals, but cause life threat-
ening disease in immunocompromised states. Importantly, 
pathogen-specific CD4 T cells play important roles in the 
control of both infections (Komanduri et al., 1998, 2001; Caruso 
et al., 1999; Gamadia et al., 2003; Bronke et al., 2005; Gallegos 
et al., 2008).
MTB-specific CD4 T cell responses are depleted in pe-
ripheral blood early after HIV infection, whereas they do not 
change appreciably over a 6–12-mo time interval in HIV-
negative subjects with latent MTB infection (Geldmacher   
et al., 2008). During chronic HIV infection, MTB-specific 
CD4 T cell responses are significantly decreased in the pe-
riphery and bronchoalveolar lavage (BAL; Geldmacher et al., 
2008; Kalsdorf et al., 2009). In contrast, CMV-specific CD4   
T cells are often detectable even late into chronic HIV infection 
(Waldrop et al., 1997). This difference provides an opportu-
nity to study cellular parameters associated with the rapid de-
pletion or persistence of pathogen-specific CD4 T cells after 
HIV infection and to further elucidate the mechanisms un-
derlying the differential rates of depletion of various pathogen-
specific CD4  T cells. A better understanding of such mechanisms 
might help to elucidate general mechanisms of HIV pathol-
ogy and to define parameters that can protect vaccine-induced 
HIV-specific CD4 T cells from preferential infection and de-
pletion upon exposure to HIV.
RESULTS
MTB-specific and CMV-specific CD4 T cell responses  
after HIV infection
To determine the effect of HIV on different pathogen-specific 
CD4 T cells in the periphery, we first compared the frequen-
cies of MTB- and CMV-specific CD4 T cell responses shortly 
before, early after, and during chronic HIV infection in sub-
jects without evidence of active TB or CMV disease. In 5 
Tanzanian subjects who acquired HIV infection during the 
study, MTB- and CMV-specific responses were detectable at 
3 mo before the first HIV seropositive study visit. During this 
baseline visit, the median frequencies of MTB- and CMV-
specific memory CD4 T cells were 0.18% (range, 0.1–0.8) 
and 0.51% (range, 0.36–2.6), respectively. The median fre-
quency of MTB-specific CD4 T cells decreased by 89.4% 
(Fig. 1) within 6–12 mo after HIV seroconversion. MTB- 
specific CD4 T cells completely disappeared in four of five 
subjects, and decreased by more than fivefold in the fifth sub-
ject. We had previously demonstrated that MTB-specific CD4 
T cells do not change appreciably over a 6–12-mo time inter-
val in HIV subjects with latent MTB infection (Geldmacher 
et al., 2008). In contrast, CMV-specific CD4 T cells were still 
detectable after 6–12 mo in all subjects, with a median de-
crease of only 40.6%, despite recent HIV infection. In four 
subjects, the frequencies of CMV-specific CD4 T cells were 
also determined during the first HIV seropositive visit and/or 
at 3 or 6 mo thereafter, but were always detectable (unpub-
lished data). The absolute decline in MTB- and CMV-specific 
CD4 T cells after HIV infection was also quantified in subjects 
subsequent slow depletion of CD4 T cells during chronic dis-
ease. Although CD4 T cell–mediated delayed type hypersen-
sitivity reactions are lost during disease progression (Blatt   
et al., 1993; Raszka et al., 1996), it is largely unclear whether 
depletion of particular pathogen-specific CD4 T cells equates 
with susceptibility to given opportunistic infectious diseases. 
Some data suggest that this might be the case; e.g., cytomega-
lovirus (CMV) end organ disease is associated with and pre-
ceded by the loss of CMV-specific CD4 T cell responses 
(Komanduri et al., 1998; Bronke et al., 2005). Whether differ-
ent pathogen-specific CD4 T cell populations are being dif-
ferentially affected by HIV and what pathogenic mechanisms 
contribute to the depletion of individual pathogen-specific 
CD4 T cells is unknown.
Pathogen-specific / () CD4 T cells play a central 
role in the orchestration of adaptive immune responses and 
are important for protective immunity to many microbial 
pathogens, including Mycobacterium tuberculosis (MTB; Caruso 
et al., 1999; Gallegos et al., 2008). CD4 T cells are a crucial 
component of the response to acute MTB infection in the 
mouse model (Mogues et al., 2001). Upon antigen recogni-
tion,  MTB-specific  CD4 T  cells  secrete  IFN-  and TNF, 
which activate infected macrophages and contribute to the 
containment of intraendosomal bacilli (Cooper et al., 1993; 
Flynn et al., 1995; Kaufmann and McMichael, 2005) and to 
the formation of bactericidal granulomas (Ray et al., 2009). 
Hence, MTB-specific CD4 T cells are thought to be of cen-
tral importance in the efficient control of MTB infection and 
prevention of further dissemination to extrapulmonary sites.
Active pulmonary and extrapulmonary tuberculosis (TB) 
are among the most commonly observed opportunistic infec-
tious diseases in HIV-infected subjects within MTB endemic 
areas, and pulmonary TB is frequently the first manifestation 
of AIDS in such regions (http://www.who.int/tb/challenges/
hiv/faq/en/, accessed on Dec third 2009). Within areas of 
high TB incidence, the risk of developing active TB is signifi-
cantly increased, even during the first year after HIV infection 
when total CD4 T cell counts are still quite high (Kaufmann 
and McMichael, 2005; Sonnenberg et al., 2005). TB was 
shown to be the cause of death in almost 50% of HIV sero-
positive South African gold miners (Murray et al., 2007). Fur-
thermore, evidence of active and disseminated TB was found 
in almost 50% of post-mortem autopsies conducted on HIV-
infected Kenyan subjects (Rana et al., 2000). In the absence of 
HIV infection or other immunodeficiencies, MTB is reason-
ably well controlled, and only 10% of MTB-exposed indi-
viduals develop active TB disease. Thus, the dramatic increase 
in active TB associated with HIV infection suggests that MTB-
specific immunity might be particularly vulnerable to HIV-
associated immune damage.
In stark contrast to pulmonary TB, which frequently oc-
curs in HIV-infected subjects with relatively high CD4 T cell 
counts, CMV-associated end organ disease typically affects 
AIDS patients only after CD4 counts have fallen to very low 
levels. Although these pathogens differ substantially, MTB and 
CMV share a range of similarities. Both cause persistent or   JEM VOL. 207, December 20, 2010 
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cross-sectional  analysis  of  HIV-infected  and  uninfected   
Tanzanian subjects (n = 17 HIV+, 17 HIV; Fig. 1, B and C).   
All subjects were clinically asymptomatic for MTB or CMV 
infection. HIV-infected subjects had a median CD4 T cell 
count of 640 cells/µl (range: 109–758). In line with previous 
studies  (Waldrop  et  al.,  1997),  CMV-specific  CD4 T  cells 
were detectable in most samples, and the median magnitude 
of the response was actually higher in HIV+ than HIV– sub-
jects (3.32 versus 1.72%, respectively). In contrast, HIV infec-
tion was associated with significantly reduced magnitudes   
(P = 0.009) and reduced prevalence of detectable MTB- 
specific responses. 6 of 17 HIV+ subjects had detectable MTB-
specific CD4 T cell responses compared with 14 of 17 in 
HIV– subjects. Collectively, these data demonstrate that early 
and chronic untreated HIV infection is associated with severe 
depletion of MTB-specific CD4 T cell responses, whereas 
CMV-specific CD4 T cell responses tend to persist. These 
data suggest that MTB-specific CD4 T cells are more suscep-
tible than CMV-specific CD4 T cells to in vivo HIV infection 
and deletion.
Phenotype and function of MTB- and CMV-specific  
CD4 T cells
To investigate factors that might be associated with the differ-
ent rates of CD4 T cell decline, we first assessed expression of 
the HIV coreceptor, CCR5, on MTB- and CMV-specific 
CD4 T cells. Although CCR5 was present on the CD4 T cells 
of both specificities, there was no difference in the expression 
of CCR5 (percentage or mean fluorescent intensity) between 
CD4 T cells of the two specificities (unpublished data).
We next examined multiple other surface maturation 
markers and several functional characteristics within the fol-
lowing groups of pathogen-specific CD4 T cells: (a) MTB- and 
CMV-specific CD4 T cells in HIV– subjects in the absence of 
active TB disease and (b) MTB-specific CD4 T cells in associ-
ation with active TB disease in HIV+ subjects (Fig. 2). Cellular 
maturation was studied using the differentiation markers CD27, 
CD45RO, and CD57, which discriminate between naive 
(CD27+CD45RO–), central memory-like (CD27+CD45RO+), 
effector memory-like (CD27–CD45RO+), and terminally 
differentiated (CD57+) CD4 T cells (Brenchley et al., 2003).
In HIV– subjects with latent TB, the majority of MTB-
specific  CD4 T  cells  had  a  CD27+CD45RO+  phenotype 
(median 64%; Fig. 2 A). A minority had a CD27–CD45RO+ 
phenotype (median 36%). CD57 expression was not detect-
able or insignificant. In contrast, MTB-specific CD4 T cells in 
HIV+ subjects with active TB were phenotypically distinct 
and were characterized by down-regulation of CD27 (me-
dian 83% were CD45RO+CD27; P < 0.001) and increased 
expression of CD57 (median 9.5%; P < 0.05). CMV-specific 
CD4 T cells also lacked CD27 expression (median 85.6% were 
CD45RO+CD27) and showed even more frequent expres-
sion of CD57 (median 48.4%).
To determine whether cell maturation was associated with 
functional changes within pathogen-specific CD4 T cells, we 
analyzed expression of IFN-, IL-2, TNF, and MIP-1 within 
with available CD4 T cell counts before and early after HIV 
infection. MTB-specific CD4 T cells declined from a median 
of 1,092 cells/ml (n = 4; range, 572–2,525) to a median of   
29 cells/ml (range, 0–427), and CMV-specific CD4 T cells 
declined  from  a  median  of  3,298  cells/ml  (n  =  5;  range, 
2,316–6,300) to a median of 1,184 cells/ml (range, 1,061–
5,457). Collectively, these data demonstrate that the rate of   
in vivo CD4 T cell depletion early after HIV infection can 
differ depending on the antigen specificity of the response.
The effect of HIV infection on the frequencies of MTB- 
and CMV-specific CD4 T cells was also determined in a 
Figure 1.  MTB- and CMV-specific CD4 T cells are lost at different 
rates after HIV infection. (A) The frequency of MTB-specific (black,  
5 PPD responding subjects, who remained TB asymptomatic) and CMV-
specific memory CD4 T cell responses (gray;  n = 6 CMV responding sub-
jects who remained CMV disease free) at 6–12 mo after HIV 
seroconversion as the percentage of baseline response detected at 3 mo 
before the first HIV-seropositive follow up in latently infected subjects. 
The frequency of MTB- or CMV-specific CD4 T cell responses in chroni-
cally HIV-infected subjects (median time since HIV infection >3 yr;  
n = 17) and a HIV control group (n = 17) is shown in B and C, respectively. 
The limit of detection is indicated. Memory CD4 T cells were defined by 
expression of CD27 and CD45RO. IFN-+ memory CD4 T cells were de-
tected after in vitro stimulation of PBMCs with PPD or whole inactivated 
CMV virus by intracellular cytokine staining. Statistical analysis was per-
formed using the Mann-Whitney test.2872 HIV-1 infection depletes MTB-specific CD4 T cells | Geldmacher et al.JEM VOL. 207, December 20, 2010 
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Effect of HIV infection on CD4 T cell function  
and phenotypes in vivo
Less IL-2 production and greater MIP-1 production among 
MTB-specific CD4 T cells in HIV+ versus HIV subjects, and 
between MTB and CMV-specific CD4 T cells (Fig. 2), is con-
sistent with the hypothesis that HIV preferentially infects and 
depletes IL-2–producing CD4 T cells and is partially inhib-
ited from infecting and depleting MIP-1–producing CD4   
T cells in vivo. We further addressed this possibility by com-
paring the proportion of CMV-specific, cytokine-producing 
cells among HIV+ and HIV subjects (Fig. 3). There was no 
difference in the proportion of IFN-– or TNF-producing 
CMV-specific CD4 T cells in HIV+ and HIV subjects. How-
ever, there was a significantly smaller proportion of IL-2– 
producing cells (P < 0.05; Fig. 3) and a significantly greater 
proportion of MIP-1–producing cells (P < 0.05, Fig. 3) in 
HIV+ versus HIV subjects. This difference was reflected in 
cells that produced MIP-1 but not IL-2 and produced IL-2 
but not MIP-1, but not in the cells that produced both ef-
fector molecules simultaneously (Fig. 3, right). Hypothetically, 
the decline in MTB-specific CD4 T cells could also be ex-
plained by selective anergy within the CD27+ memory CD4 
compartment or selective depletion of this compartment   
after HIV infection. However, the functional capacity of the 
CD27+ memory CD4 compartment upon staphylococcal en-
terotoxin B (SEB) stimulation was not compromised after HIV 
infection and the proportion of CD27+ memory CD4 compart-
ment remained constant after HIV infection in six HIV sero-
converters (unpublished data).  These data are therefore consistent 
with the hypothesis that with HIV infection in vivo, IL-2–
producing cells are more likely to get infected and depleted 
than MIP-1–producing cells.
IL-2 dependence of HIV infection in vitro
The in vitro inhibitory effects of CCR5 ligands on HIV   
infection have been previously described (Cocchi et al., 1995; 
Kinter et al., 1996; Paxton et al., 1996). To explore whether 
endogenous IL-2 production augments in vitro HIV infection, 
we performed HIV infection experiments in the presence or 
absence of a neutralizing anti–IL-2 antibody. SEB-stimulated 
PBMCs  were  infected  with  the  CCR5-tropic  HIV  strain 
the three different groups of CD4 T cells and delineated the 
functions according to their maturational phenotype. As shown 
in Fig. 2 B, diametrically opposed patterns of IL-2 and MIP-1 
production  were  detected  in  MTB-specific  CD4 T  cells 
among HIV TB asymptomatic subjects and CMV-specific 
CD4 T cells (right). Large fractions of CMV-specific CD4   
T cells produced MIP-1 (median, 62%), but few produced IL-2 
(median, 20%). In contrast, most MTB-specific CD4 T cells in 
asymptomatic infection produced IL-2 (P < 0.001; median, 
54%), but not MIP-1 (P < 0.001; median, 3%). Differences 
in MIP-1 and IL-2 production occurred throughout the   
16 possible cytokine combinations (bottom). No such differ-
ences were detected for TNF or IFN- production (unpub-
lished data). MTB-specific CD4 T cells in HIV+ subjects with 
active TB were functionally distinct from those in HIV sub-
jects during asymptomatic TB infection. The median fraction 
of MIP-1+ cells was higher (29%; P < 0.05), whereas the 
median fraction of IL-2+ cells was lower (32%; P < 0.05) in 
HIV+ subjects with active TB as compared with the response 
in HIV subjects with latent TB. Most notably, the subset of 
three  functional  cells  that  produced  MIP-1,  IFN-,  and 
TNF, but no IL-2, which is characteristic of the CMV- 
specific CD4 T cell response, was virtually absent from MTB-
specific CD4 T cells during latent TB, but present during 
active TB.
Whether these distinct functional properties were associ-
ated with different cellular maturation was then analyzed 
by comparing pathogen-specific IL-2 and MIP-1 produc-
tion by CD27+CD45RO+, CD27CD45RO+CD57, and 
CD27CD45RO+CD57+ CD4 T cells. A representative dot 
plot (left) for IL-2 and MIP-1 production for each group and 
for all studied responses (right) is shown in Fig. 2 C. Independent 
of the pathogen specificity, a CD45RO+CD27 phenotype   
was associated with more MIP-1+ and fewer IL-2+, cells.   
Large fractions of CD27CD45RO+CD57+ CD4 T cells   
were only present within the CMV-specific response, and   
almost all expressed MIP-1 exclusively. Virtually none of the 
CD27CD45RO+CD57+ cells produced IL-2, irrespective of 
specificity. Together, these data suggest that the capacity to pro-
duce IL-2 is reduced, whereas the capacity to produce MIP-1 
is increased, with maturation of pathogen-specific CD4 T cells.
Figure 2.  Differences in cellular maturation between MTB- and CMV-specific CD4 T cells are diminished during active TB disease and are 
associated with diametrically opposed production of IL-2 and MIP-1. (A) Surface expression of the maturation markers CD27, CD45RO, and CD57 
on total CD4 T cells (black) is shown for representative subjects as a density plot overlay. MTB-specific CD4 T cells in the absence (blue, HIV) or presence 
(green, HIV+) of active TB disease and for CMV-specific CD4 T cells (red). The percentage of CD27+CD45RO+, CD27CD45RO+, and CD57+ subsets within 
MTB- and CMV-specific CD4 T cells from HIV subjects (blue, n = 17) and HIV+ subjects with active TB (green, n = 11; bottom). (B) Flow cytometric analy-
sis of IFN-, IL-2, MIP-1, and TNF production within pathogen-specific CD4 T cells. PBMCs from subjects with latent MTB infection (defined by positive 
response to region of difference 1 [RD1] antigens) or from HIV+ subjects with active TB were stimulated with MTB-antigens (PPD or a mix of PPD and RD1 
peptide pools) or CMV whole antigen. The pie charts show the fraction of cells with 1, 2, 3, or 4 functions. The color-coded circles indicate the proportion 
of the 4, 3, 2, and 1 functional responses response that are contributed by the single cytokines IFN- (red), IL-2 (blue), Mip-1 (green), and TNF (pink).  
The fraction of cells that produce MIP-1 (right top) or IL-2 (bottom right) is shown as percentage of total cytokine-positive CD4 T cells. The median is 
indicated. Further delineation of the 16 different possible cytokine combinations is shown (bottom). (C) Intracellular staining of IL-2 (y axis) and MIP-1 
(x axis) within CD27+CD45RO+, CD27CD45RO+CD57, and CD27CD45RO+CD57+ CD4 T cells after stimulation with PPD or CMV is shown for one repre-
sentative subject (left) and for all studied responses further delineated by IL-2 and MIP-1 production and presented as percentage of total cytokine-
positive response (right). Statistical analysis was performed using the Mann-Whitney test (***, P < 0.0005; **, P < 0.005; *, P < 0.05).
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(AZT; Fig. 4 A). In the absence of the IL-2 neu-
tralizing antibody, 48% of dividing cells (CFSElow), 
but only 2.2% of the cells that had not undergone 
cell division were p24+ (Fig. 4 B, top). Virtually all 
of these p24+ cells expressed CD25, demonstrat-
ing that productive HIV infection occurred within 
cells that could respond to IL-2 signaling. Neutral-
ization of IL-2 resulted in a 12.5-fold reduction of 
p24+ cells and completely abrogated cell division 
(Fig. 4 B, bottom). The fraction of CD25+ cells 
was reduced by 60% (Fig. 4 B, bottom), whereas 
the fraction of CCR5+ cells was unaffected by the 
anti–IL-2 treatment, indicating that neutralization 
of IL-2 did not affect HIV replication through modulation of 
the coreceptor, but by affecting post-entry events associated 
with cell division. These data demonstrate that productive 
HIV-infection of SEB-stimulated CD4 T cells is associated 
with CD25 expression, cell cycle induction, and the produc-
tion of IL-2 upon TCR engagement.
We  next  analyzed  the  expression  of  CD25  on  IL-2+ 
MIP-1 and IL-2MIP-1+ CD4 T cells after 6 h SEB stimu-
lation. Fig. 5 A shows a single experiment, and Fig. 5 B shows   
the composite results from seven experiments. These data 
BAL, and CD4 T cells were analyzed for HIV p24 content in 
the context of cell division and CD25 and CCR5 surface ex-
pression (in the absence of exogenously added IL-2). We also 
attempted stimulation with purified protein derivative (PPD) 
in this experimental set up. However, the frequency of respond-
ing cells was so low that there were too few events in which 
to accurately measure HIV infection. The p24 staining in this 
system was the result of active viral replication, and not re-
tained p24 from the virus inoculum, as it was inhibited by the 
addition of the reverse transcription inhibitor azidothymidine 
Figure 3.  HIV infection is characterized by increased 
fractions of MIP-1+ and decreased fractions of IL-2+ 
CMV-specific CD4 T cells. (left) The fraction of IFN-+, 
TNF+, MIP-1+, or IL-2+ among total cytokine positive CD4  
T cells (y axis) is shown for HIV (n = 11) and HIV+ subjects 
(n = 16). (right) The fraction of IL-2+MIP-1+, IL-2+MIP-1, 
and IL-2MIP-1+ among total cytokine-positive CD4  
T cells. PBMCs were stimulated overnight with whole inacti-
vated CMV and the background (unstimulated control) was 
subtracted. Statistical analysis was performed using the 
Mann-Whitney test.
Figure 4.  Productive HIV-1 infection of SEB-responding CD4 T cells is inhibited by in vitro neutralization of IL-2. (A) Productive HIV infection 
of CD4 T cells was analyzed after gating on CD4low T cells and staining for HIV-p24 (y axis). Shown are dot plots from samples stimulated in the presence 
or absence of 1 µM AZT. (B) Dot plots from samples stimulated in the presence (bottom) or absence (top) of a neutralizing anti–IL-2 antibody comparing 
CFSE-fluorescence intensity (left), surface CD25 (middle), and CCR5 (right) with HIV-p24 staining. PBMC samples were stimulated for 24 h with SEB and 
then infected for another 24 h with the CCR5 tropic HIV-1 strain BAL.JEM VOL. 207, December 20, 2010 
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Cytokine expression delineates in vivo infection history  
of MTB-specific T cells
To determine in vivo cellular infection rates within MTB-
specific and nonspecific memory CD4 T cells, we stimulated 
PBMCs from HIV/MTB coinfected subjects with a mix of 
PPD, early secretory antigenic target 6 (ESAT6), and culture 
filtrate protein 10 (CFP10), sorted the CD4 T cells accord-
ing to cytokine and chemokine expression (Fig. 7 A), and 
quantified the HIV gag DNA within the different subsets. 
Despite relatively low numbers of sorted cytokine/chemo-
kine+ cells, we were able to quantify proviral DNA in 16 
responding MTB-specific CD4 T cell populations from 10 
HIV-infected subjects with active TB. We first compared the 
number of HIV gag DNA copies within MTB-specific, cyto-
kine/chemokine+ CD4 T cell samples with the nonrespond-
ing CD4 memory T cell compartment (CD27+CD45RO+, 
CD27CD45RO+, and CD27CD45RO subsets). In 9 of 
10 subjects, the number of HIV gag DNA copies detected in 
MTB-specific CD4 T cells was higher compared with total 
memory CD4 T cells (median 2.5-fold increase; P < 0.01; 
Fig. 7 C). Next, we determined whether MTB-specific CD4 
T cells expressing different patterns of IL-2 and MIP-1 
contained different amounts of HIV gag DNA. MTB-spe-
cific CD4 T cells that exclusively expressed either MIP-1 
or IL-2 were virtually nonexistent. The median number 
of HIV gag DNA copies per 10,000 cells was 1,426.5 for 
IFN+IL-2+MIP-1TNF+  (range  109–127,500  mean), 
538 for IFN+IL-2MIP-1TNF+ (range, 29–34,167), 315 
for MIP-1+TNF+ (range, 278–6,136), and 268 for cytokine 
negative memory CD4 T cells (range, 8–19,370). To reduce 
the inherent patient-to-patient variability in the HIV gag 
DNA copy numbers, and overcome the fact that many of the 
sorted samples contained too few cells to register a signal in 
the PCR assay, the results were expressed as a ratio of HIV 
gag DNA copies in cytokine+/cytokine cells (Fig. 7 B). 
Consistent with the aforementioned raw data calculations, 
the IL-2–producing MTB-specific CD4 T cells 
tended to harbor greater numbers of HIV gag 
copies per cell as compared with the IL-2 and 
MIP-1+ cells, although this trend was not sta-
tistically significant within this small number 
of subjects. Together, these data support the hy-
pothesis that the functional characteristics, and 
in particular the capacity to secrete IL-2 but 
demonstrate  that  a  median  of  39.5%  of  IL-2+MIP-1,   
but only 6.6% of MIP-1+IL-2 CD4 T cells express CD25 
after stimulation. The expression of CD25 on the MIP-1+ 
IL-2 CD4 T cells is the same as on all other nonrespond-
ing memory CD4 T cells, suggesting that IL-2 is specifically 
and intimately linked to expression of its high-affinity re-
ceptor, CD25.
We next analyzed in vitro HIV infection of SEB-stimulated 
CD4 T cells according to their expression pattern of MIP-1, 
IFN-, and IL-2 (Fig. 6). Within the responding CD4 T cell 
populations, we were able to gate upon cells with cytokine 
profiles that match either CMV- (MIP-1+IL-2) or MTB-
specific (MIP-1IL-2+) CD4  T cells. CD4  T cells with a cyto-
kine profile matching that of MTB-specific T cells had higher 
HIV infection rates as compared with those matching CMV-
specific T cells (P = 0.03).
Figure 5.  The capacity to secrete IL-2 by antigen-specific CD4  
T cells is associated with increased CD25 expression. (A) Representative 
histogram of the CD25 expression on cytokine-negative, MIP-1+IL-2, 
and MIP-1IL-2+ CD4 T cells after 6 h of SEB stimulation of PBMCs.  
(B) The fraction of CD25+ CD4 T cells among the same subsets (n = 7). 
Statistical analysis was performed using the Mann-Whitney test.
Figure 6.  In vitro HIV infection of cytokine- 
expressing cells. (A) Representative histograms of the 
HIV p24 staining from CD4 T cells delineated by intracel-
lular staining for MIP-1, IFN-, and IL-2 and (B) the 
fraction of p24+ CD4 T cells delineated by intracellular 
staining for MIP-1, IFN-, and IL-2 from six indepen-
dent experiments. PBMC samples were stimulated for 
24h with SEB and then infected for another 24 h with 
the CCR5 tropic HIV-1 strain BAL. Productive HIV infec-
tion of CD4 T cells was analyzed after gating on CD4low  
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to differential HIV infection of antigen-specific CD4 T cells   
in vivo.
We have previously shown that MTB-specific CD4 T cells 
express  comparatively  high  levels  of  the  HIV-coreceptor 
CCR5. However, CCR5 expression was similar on MTB- 
and CMV-specific CD4 T cells (unpublished data) indicating 
that coreceptor expression alone could not account for any 
difference in rates of depletion after HIV infection between 
MTB- and CMV-specific CD4 T cells. Instead, we found   
significant differences in the capacity of MTB- and CMV- 
specific CD4 T cells to produce IL-2 and the CCR5 ligand 
MIP-1. CMV-specific CD4 T cells tended to produce MIP-1 
but not IL-2, and displayed an effector memory phenotype and 
this functional profile that was even more pronounced during 
chronic HIV infection, whereas MTB-specific CD4 T cells 
produced IL-2 but not MIP-1, and were less mature. Cells 
producing IL-2 in the absence of MIP-1 were more suscepti-
ble to productive HIV infection within SEB-activated CD4   
T cells in vitro (Fig. 6) and this functional profile within MTB-
specific CD4 T cells was associated with a greater frequency   
of HIV gag DNA in vivo (Fig. 7). These observations together 
with the striking differences in the depletion dynamics between 
MTB- and CMV-specific CD4 T cells early after HIV infection 
suggest that these differences in function contribute to differen-
tial cellular susceptibility to HIV infection and depletion of 
these two cell populations, and the associated differences in dis-
ease onset caused by these opportunistic pathogens.
The capacity of CCR5 ligands to block HIV replication   
in vitro is well established (Cocchi et al., 1995, Kinter et al., 
1996). Indeed, CD4 T cells with a relative resistance to CCR5-
tropic HIV strains are capable of producing comparatively 
not MIP-1 upon MTB-specific stimulation, are associated 
with increased susceptibility of MTB-specific CD4 T cells to 
HIV infection.
DISCUSSION
We  have  previously  demonstrated  that  MTB-specific  CD4   
T cells are depleted from the periphery early after HIV infec-
tion, whereas in HIV subjects the frequencies of MTB- 
specific CD4 T cells do not change appreciably over time 
(Geldmacher et al., 2008). In contrast, CMV-specific CD4   
T cells are frequently detectable in the periphery during chronic 
HIV infection (Waldrop et al., 1997) and contain compara-
tively little proviral DNA (Douek et al., 2002). In this study, 
we detected significantly higher levels of HIV gag DNA in 
MTB-specific CD4 T cells than in total memory CD4 cells in 
the periphery. The higher levels of HIV gag DNA within 
MTB-specific CD4 T cells (ratio of 2.5 to total memory CD4 
T cells) are comparable to those observed in HIV-specific 
CD4 T cells (ratio 3.4; Douek et al., 2002). Brenchley et al. 
(2006) have previously shown that HIV-specific CD4 T cells 
are present at very low frequencies in most HIV+ individuals 
and that direct HIV infection of virus-specific CD4 T cells re-
duces their life span in vivo. In this context, these data support 
the hypothesis that direct HIV infection of MTB-specific 
CD4 T cells contributes to their depletion, possibly compro-
mising the generation of effective immune responses to MTB 
in HIV-infected subjects. We thus explored which functional 
and phenotypic characteristics might account for the higher 
infection rates and more rapid depletion of peripheral MTB-
specific CD4 T cells after HIV infection and tested the   
hypothesis that differences in specific functions might contribute 
Figure 7.  In vivo HIV gag DNA in MTB- 
specific CD4 T cells. (A) Gating/sorting strategy 
used to sort different memory CD4 T cell popula-
tions delineated by IFN-, IL-2, and MIP-1 produc-
tion. MIP-1 memory CD4 T cells were further 
delineated into IFN+IL-2+TNF+, IFN+IL-2TNF+, 
and cytokine-negative memory CD4 T cells. The HIV 
gag DNA/10,000 cells determined within these popu-
lations is indicated. (B) The ratio of HIV gag copies/ 
10,000 cells detected within cytokine-positive to 
cytokine-negative memory T cells from 16 cytokine-
positive CD4 T cell populations sorted from  
10 HIV+ subjects (different symbols) with active TB.  
(C) The mean number of gag copies/10,000 cells 
detected in MTB-specific CD4 T cells or total mem-
ory CD4 T cells is shown for each subject. Memory 
CD4 T cells were defined by expression of CD45RO 
and CD27. The PBMCs were stimulated overnight 
with a mix of PPD and RD1 peptide pools and fur-
ther analyzed as described in the Materials and 
methods section. Gag DNA within different CD4  
T cell populations of the same subject was quanti-
fied during the same RT-PCR run. The statistical 
analysis in C was performed using the  
Wilcoxon-rank-matched pairs test.JEM VOL. 207, December 20, 2010 
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infection and depletion. However, despite the large numbers 
of PBMCs used for a single experiment (3 × 107), the number 
of sorted MTB-specific CD4 T cells with different functional 
profiles was often too low to detect HIV DNA, and larger stud-
ies will be needed to expand upon this finding. The capacity 
to produce IL-2 in the absence of MIP-1 might create a 
microenvironment that very efficiently drives the replication 
of HIV within MTB-specific CD4 T cells. Indeed, the enormous 
potential of MTB-specific immune responses to contribute to 
an explosive replication of a single virus quasi species in vivo 
has been demonstrated within simian immunodeficiency   
virus (SIV)–infected Rhesus macaques; up to 35% of viral 
quasi species in PBMCs were closely related to the single   
major species that was isolated at the site of the tuberculin 
skin test (Cheynier et al., 1998).
Impact of function and phenotype on HIV infection
Activated, CD25-expressing CD4 T cells that are HIV in-
fected have been shown to preferentially undergo apoptosis in 
lymphoid tissue explants (Biancotto et al., 2008), and SIV in-
fection of CD4 T cells at mucosal sites can reach extremely 
high frequencies during acute infection (Mattapallil et al., 
2005). Our observations support the hypothesis that MTB-
specific IL-2+MIP-1 CD4 T cells might represent a pool 
of CD4 T cells that are highly susceptible to HIV infection 
and may become rapidly depleted upon HIV infection before 
they can further differentiate into effector cells, a general 
mechanism that has been proposed previously for the deple-
tion of memory CD4 T cells (Grossman et al., 2006; Okoye   
et al., 2007). In this scenario, the few MTB-specific CD4 T cells 
that avoid HIV infection could go on to mature further, and 
in the process gain expression of MIP-1 and lose IL-2 ex-
pression, simultaneously making them less susceptible to HIV 
infection. The resulting shift from IL-2 expression to MIP-1 
expression concomitant with loss of CD27 and gain of CD57 
expression that is predicted by this model is exactly what we 
observed in MTB- and CMV-specific CD4 T cells in individ-
uals who were infected with HIV (Fig. 2 C). Collectively, our 
observations support the hypothesis that antigen-specific   
IL-2 production, particularly in the absence of CCR5 ligand 
MIP-1, contributes to the productive HIV infection and 
subsequent depletion of MTB-specific CD4 T cells early after 
HIV infection.
During clinically latent TB, the majority of MTB-specific 
CD4 T cells expressed CD27 and can be considered as having 
a central memory-like phenotype (CCR7 was not measured); 
however, they also expressed higher levels of CCR5 compared 
with the total memory compartment (Geldmacher et al., 
2008). In contrast, CMV-specific CD4 T cells had a highly 
differentiated effector memory-like phenotype. HIV infec-
tion was associated with a significantly increased fraction of 
senescent, CD57+ cells (Brenchley et al., 2004) and MIP-1+ 
cells, and a reduced fraction of cells with the capacity to pro-
duce IL-2. Similarly, in HIV patients with active TB, MTB-
specific CD4 T cells were characterized by a more mature 
CD27low  phenotype,  a  detectable  fraction  of  CD57+  and 
high amounts of such CCR5 ligands, including MIP-1  
(Paxton et al., 1996). We have recently shown that CMV- 
specific  CD4 T  cells  that  produce  MIP-1  and  MIP-1  
contain 10-fold less HIV gag DNA than CMV-specific CD4 
T cells that do not produce these chemokines (Casazza et al., 
2009). These data indicate that autocrine production of MIP-1 
protects CD4 T cells from HIV infection in vivo. Thus, the 
lack of MIP-1 production by the less mature MTB-specific 
CD4 T cells might contribute to their increased susceptibility 
to HIV infection and subsequent depletion. In contrast, the 
production of MIP-1 by the more mature CMV-specific 
CD4 T cells is likely to contribute to their relative resistance 
to HIV infection (Douek et al., 2002; Casazza et al., 2009), 
and thus to their persistence after HIV infection. Our obser-
vation that HIV infection is associated with further increased 
proportions of MIP-1+ but decreased proportions of IL-2+ 
CMV-specific CD4 T cells is in line with these findings and 
with our hypothesis that the functional profile of pathogen-
specific CD4 T cells might influence their susceptibility to 
HIV. Indeed, as a common theme, the tendency of more dif-
ferentiated CD4 T cells to produce MIP-1 could explain the 
previously described low HIV infection rates within CD57+ 
CD4 T cells in vivo (Brenchley et al., 2003).
IL-2 signaling pathway and HIV infection
Whereas MTB-specific CD4 T cells lacked the capacity to 
produce MIP-1 in individuals with latent MTB infection, 
they had a remarkable capacity to produce IL-2. IL-2 and its 
high-affinity IL-2 receptor -chain CD25, whose expression 
rapidly increases upon T cell receptor engagement, are im-
portant in driving T cells into the cell cycle. In addition to 
being critical for T cell proliferation, IL-2 may also positively 
impact upon HIV reverse transcription (Zack et al., 1990) by 
increasing the concentration of dNTPs in CD25+ CD4   
T cells. Indeed, CD25 expression and productive HIV infec-
tion appear to be linked; in vitro depletion of CD25+ CD4   
T cells efficiently blocks viral replication (Finberg et al., 1991;, 
Ramilo et al., 1993; Chou et al., 1997). CD25 expression on 
CD4 T cells correlates with PPD-induced HIV replication 
(Goletti et al., 1996), and it was recently demonstrated that 
productive HIV-1 infection within lymphoid tissue explants 
occurred predominantly in CD4 T cells expressing CD25 
(Biancotto et al., 2008). In vivo, CD25+ CD4 T cells contain 
up to sevenfold more immunodeficiency virus during acute 
infection, a phenomenon that was particularly apparent within 
lymph  nodes  (Mexas  et  al.,  2008).  Our  observations  that   
in vitro neutralization of IL-2 reduced CD25 up-regulation, 
abrogated antigen-specific CD4 T cell proliferation, and al-
most completely abrogated productive HIV infection of 
CD4 T cells supports a central role for the IL-2–CD25 sig-
naling pathway in the productive infection of antigen-specific 
CD4 T  cells.  Our  finding  that  peripheral  MTB-specific 
CD4 T cells with the capacity to produce IL-2, but not MIP-1, 
contained the highest amount of HIV gag DNA in vivo   
supports the conclusion that IL-2 expression by MTB-specific 
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Mbeya region of Southwest Tanzania, which is described in detail elsewhere 
(Riedner et al., 2003; Herbinger et al., 2006). Subjects with evidence of active 
TB were enrolled at the NIMR-Mbeya Medical Research Program (NIMR-
MMRP) Tuberculosis Clinic in collaboration with the National Tuberculosis 
and Leprosy Program of Tanzania (NTLP). The purpose and the procedures 
of the study were explained thoroughly to potential participants. Only per-
sons who gave voluntarily written informed consent in the presence of   
a witness were enrolled. Acid Fast Bacilli smear positive TB patients were re-
ferred to the MMRP Tuberculosis clinic. Active TB was diagnosed by exami-
nation and culture (BACTEC MGIT; BD) of three separate sputum samples 
per patient. HIV status was determined using HIV 1/2 STAT-PAK (Chem-
bio Diagnostic Systems) and positive results were confirmed using Enzygnost 
Anti-HIV 1/2 Plus ELISA (Siemens). Patients eligible for TB treatment were 
referred to the NTLP for treatment according to national guidelines. Patients 
diagnosed with HIV infection were referred to the Southern Highland Care 
and Treatment Program. None of the subjects evaluated in the current study 
were on active antiretroviral therapy.
In addition, blood was obtained from HIV-positive antiretroviral therapy 
naive Ghanaian patients with suspected TB attending the HIV clinic of   
Koforidua Hospital, Ghana, after informed consent. Ethical clearance was 
granted by the Institutional Review Board of the Noguchi Memorial Insti-
tute for Medical Research, NMIMR-IRB CPN 039/06-07. HIV infection 
was confirmed using the Determine HIV-1/2 test (Abbott) and the First 
Response HIV 1–2.0 test (Premier Medical Corporation Ltd).
PBMCs from these patient cohorts were isolated, cryopreserved, stored 
in liquid nitrogen, and used in subsequent immunological assays. Use of these 
patient materials was reviewed and approved by the ethics committees of all 
partners in compliance with national guidelines and institutional policies.
Conjugated antibodies.  The following antibodies were used: IFN-–FITC, 
IL-2-allophycocyanin (APC), MIP-1-PE, CD3-Cy7APC, CCR5-Cy7PE 
and CD25-Cy5PE (BD), CD27-Cy5PE and CD45RO-Texas red-PE (Beck-
man Coulter), and CD4-PECy5.5 (Invitrogen) and anti-HIV p24/p55 anti-
body (PE or FITC; clone KC57; Beckman Coulter). CD8-quantum dot 
(QD) 655, CD57-QD565, and TNF-Alexa Fluor 680 were conjugated in 
accordance with standard protocols (http://drmr.com/abcon/index.html).
Antigens. For cell stimulations, PPD (Statens Serum Institut) was used at a 
final concentration of 10 µg/ml. 2 µl of undiluted CMV grade 2 antigen 
(Microbix) was used to stimulate PBMC. Peptides 15 aa in length and over-
lapping by 11 aa were designed for ESAT6 (AF420491.1) and CFP10 
(AAC83445) by using the PeptGen peptide generator from the HIV Molecu-
lar Immunology Database (http://www.hiv.lanl.gov/content/immunology/) 
and were used at a final concentration of 2 µg/ml/peptide. For sorting ex-
periments, MTB-specific CD4 T cells were stimulated overnight with a mix 
of PPD, ESAT6, and CFP10 peptides to maximize detection of the MTB-
specific T cell population.
Stimulation  and  flow  cytometric  analysis. Previously cryopreserved 
PBMCs were recovered by thawing and washing twice in Benzonase (4 µl of 
25 kU Benzonase in 20 ml; Novagen) containing 37°C complete media 
(CM; 10% heat inactivated fetal calf serum, 100 U/ml penicillin G, 100U/ml 
streptomycin sulfate, and 1.7 mm sodium glutamine). Cell stimulation was 
performed in CM in the presence of 1 µg/ml each of anti-CD28 and anti-
CD49d (BD). Duration of stimulation varied in different assays. For the de-
tection of MTB- and CMV-specific CD4 T cell responses and analysis of 
their functionality and cell surface phenotype, PBMCs were stimulated with 
specific antigens for 2 h before adding Brefeldin A (BFA; Sigma-Aldrich), and 
then further incubated overnight (14–18 h; 6 h for analysis of CD25 expres-
sion) at 37°C. For in vitro HIV infection experiments, PBMCs were stimu-
lated for 48 h and BFA was added 4 h before flow cytometric analysis. 
Staining was performed using a modified version of a previously described 
method (Betts et al., 2006). After stimulation, PBMCs were washed once with 
PBS and stained with Vivid/Aqua (Invitrogen; Perfetto et al., 2006). Anti-
CCR5 antibody was then added for 10 min at room temperature in the dark. 
MIP-1+ CD4 T cells, and a reduced capacity to produce   
IL-2. These differences might also be driven by the strength 
and persistence of T cell receptor engagement and thus differ-
ent patterns of pathogen reactivation might contribute to the 
phenotype and function of pathogen-specific CD4 T cell re-
sponses and also to their persistence or reappearance after 
HIV infection; indeed CMV viral replication can be detected 
in almost 20% of HIV infected subjects (Griffin et al., 2008, 
Slyker et al., 2009) and MTB reactivation might account for 
the change in phenotype and function in subjects with active 
as compared with latent TB (Streitz et al., 2007). However, 
CD4 T cells targeting cleared antigens, such as the flu or the 
tetanus toxin, and with the capacity to produce IL-2 are also 
disproportionally depleted (Tilton et al., 2007) upon anti-
retroviral  treatment  interruption,  suggesting  that  this  phe-
nomenon cannot be solely explained by enhanced stimulation, 
TCR driven maturation and associated changes in function-
ality. Thus, increased HIV infection among those cells still ca-
pable of producing IL-2 might preferentially deplete these less 
mature, central memory-like CD4 T cells.
Because our study focuses on the phenotype and function of 
antigen-specific cells within the periphery, we are unable to ad-
dress the impact of antigen-specific T cell functional changes, as 
they occur after antigen exposure in other tissues, nor can we 
rule out specific migration of cells with certain phenotypes or 
functions as an explanation for the changes we observe. How-
ever, other published data suggest that MTB-specific CD4 T cells 
are depleted also from the BAL of HIV infected, TB asymptom-
atic subjects from a TB endemic area (Kalsdorf et al., 2009).
Implications for vaccines
Preferential  infection  of  vaccine-induced,  HIV-specific  CD4   
T cells might reduce efficiency of vaccine-induced immunity. 
Our results help to define cellular parameters associated with HIV 
infection and either depletion or persistence of antigen-specific 
CD4 T cells. These findings could help define the type of CD4 
response one would hope to induce with a HIV vaccine. Indeed, 
just recently it has been shown that vaccination with replication 
competent, recombinant CMV was able to induce differentiated, 
MIP-1–producing HIV-specific T cells that were associated 
with protection against SIV challenge (Hansen et al., 2009).
In conclusion, our data suggest that specific functional and 
maturational characteristics of MTB-specific CD4 T cells might 
contribute to increased HIV susceptibility and their subsequent 
depletion after HIV infection. Strong antigenic stimulation dur-
ing active TB might obscure this depleting effect, despite high 
infection (and turnover) rates of MTB-specific memory CD4   
T cells, and at the same time might drive phenotypic and func-
tional changes that confer partial cellular resistance to HIV infec-
tion. These results suggest that MTB-specific adaptive immunity 
is particularly vulnerable to HIV-associated immune damage.
MATERIALS AND METHODS
Study subjects. Subjects from three cohorts were included in this study. 
Most were part of a large, well-characterized, high-risk cohort of female bar 
workers (HISIS) enrolled in a prospective study of HIV-1 infection in the JEM VOL. 207, December 20, 2010 
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detection and quantification of East African subtype A and C strains. Gag 
primer position and sequences were as follows, 783gag, forward, 5-GAGA-
GAGATGGGTGCGAGAGCGTC-3 (Tm>60), 895gag, reverse, 5-CTKT-
CCAGCTCCCTGCTTGCCCA-3  (Tm>60);  FAM-labeled  probe 
844gagPr,  5-ATTHGBTTAAGGCCAGGGGGAARGAAAMAAT-3. 
Sites where base sequences differed among HIV isolates were made degener-
ate and are noted as follows: where degenerate bases are denoted as R (A or G), 
M (A or C), K (G or T), H (A or C or T), and B (C, G, or T). To quantify the 
cell number in each reaction mix, the human albumin gene copy number 
was also assessed by qPCR. Albumin primer and probe sequences were as 
follows: hAlb, forward, 5-TGCATGAGAAAACGCCAGTAA-3; hAlb, re-
verse, 5-ATGGTCGCCTGTTCACCAA-3; and hAlbProbe, 5-FAM- 
TGACAGAGTCACCAAATGCTGCACAGAA-BHQ1-3. Sorted T cells 
were lysed in 0.1 mg/ml proteinase K buffered with Tris-Cl for 1 h at 56°C, 
and then for 10 min at 95°C to inactivate the enzyme. 5 µl of lysate was used 
in a total reaction volume of 25 µl containing 12.5 µM primers, 5 µM probe, 
a 10-mM concentration of each deoxynucleoside triphosphate, 3.5 mM 
MgCl2, 1.25 mM blue 636 reference dye, and 0.625 U platinum Taq in the 
supplied buffer. Reaction conditions included 5-min activation at 95°C, fol-
lowed by 15 s at 95°C and 1 min at 60°C for 45 cycles. Quantification was 
generated using standard curves for HIV-1 gag and albumin. Cell-associated 
gag DNA from different T cell subsets from the same subjects were quantified 
during the same PCR run to assure comparability of the results.
Statistical analysis. Data analyses were performed using Prism version 4.0 
software (GraphPad, Inc.). Comparisons of two groups were performed using 
the Mann-Whitney test. Comparisons of paired groups were performed   
using the Wilcoxon matched pairs test. Tests used for statistical analysis are 
described in the figure legends.
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Subsequently, surface proteins were stained for 20 min. The cells were per-
meabilized using the Cytofix/Cytoperm kit (BD), after which they were 
stained for CD3, IFN-, MIP-1, IL-2, and TNF. Cells were then washed 
and fixed with 1% paraformaldehyde. Cells were analyzed with a modified 
flow cytometer (LSR II; BD). Between 300,000 and 1,000,000 total events 
were collected from each sample. Electronic compensation was conducted 
with antibody capture beads (BD) stained separately with the individual   
antibodies used in the test samples. Flow cytometry data were analyzed using 
FlowJo (version 8.8.3; Tree Star, Inc.). For polychromatic analysis, initial gat-
ing for each sample set used a forward scatter area versus a forward scatter 
height plot to gate out cell aggregates. The cells were then gated through a 
forward scatter area versus a side scatter height plot to isolate small lympho-
cytes. A CD3 versus Vivid/Aqua plot was then used to remove dead cells. 
The cutoff point for positive CD4 T cell responses was 2-fold the negative con-
trol and at least 0.1% cytokine positive after subtraction of the background.
Virus  growth  and  characterization.  CCR5-tropic  HIV-1  BAL  was 
grown on phytohemagglutinin (PHA; Sigma-Aldrich)-stimulated PBMCs in 
CM supplemented with IL-2 (Chiron). HIV p24 antigen in cell culture su-
pernatants was monitored by ELISA (Beckman Coulter).  Virus was harvested 
at the peak of infection, on either day 4 or 7. Viruses were concentrated by 
ultracentrifugation at 30,000 rpm for 70 min at 4°C, and virus pellets were 
resuspended in fresh RMPI at 10–50× to obtain clean, concentrated virus 
stocks.  Control  concentrated  conditioned  supernatant  from  uninfected 
PHA-stimulated T cells was collected as a control. The viral titers were deter-
mined by sensitive 14-d end-point titration assays using PHA- and IL-2–
stimulated PBMC, and listed as 50% tissue culture infectious doses per ml 
(TCID50/ml), as described previously (Mascola et al., 1996). The final titer of 
the stock of HIV Bal was 2.6 × 106 TCID50/ml.
In vitro HIV infection of primary CD4 T cells. Previously cryopre-
served PBMCs were thawed for co-culture, washed thoroughly, and labeled 
with 0.25 µM CFSE fluorescent dye (Invitrogen). CFSE-labeled cells were 
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